Capital Advantage’s Medtronic MDT Stock Holding History

Capital Advantage’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-3,120	Closed	-$369K	–	84
2021 Q1	$369K	Buy	3,120 +400	+15%	+$46.9K	0.1%	78
2020 Q4	$318K	Buy	2,720 +132	+5%	+$14.5K	0.09%	80
2020 Q3	$273K	Sell	2,588 -32	-1%	-$3.21K	0.09%	75
2020 Q2	$240K	Buy	2,620 +156	+6%	+$15K	0.09%	76
2020 Q1	$255K	Buy	2,464 +503	+26%	+$53.5K	0.1%	70
2019 Q4	$234K	Buy	+1,961	New	+$215K	0.07%	83
2015 Q2	–	Sell	-2,864	Closed	-$223K	–	74
2015 Q1	$223K	Hold	2,864	–	–	0.09%	67
2014 Q4	$207K	Buy	+2,864	New	+$199K	0.09%	67

Other funds holding MDT

WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Advantage's MDT Position: Q2 2021 in Review

Capital Advantage sold out of Medtronic (MDT) in Q2 2021, closing a stake of 3,120 shares — an estimated $369K sold.

Capital Advantage first reported a position in MDT in Q4 2014 and held it in 8 quarters. The position peaked at $369K in Q1 2021. 2,003 funds tracked by Wall St. Rank hold MDT as of Q2 2021.

Capital Advantage reported no remaining Medtronic position as of Q2 2021 after selling out during the quarter.
Capital Advantage sold 3,120 Medtronic shares in Q2 2021, an estimated $369K.
Capital Advantage first reported a position in Medtronic in Q4 2014 and held it in 8 quarters.
Capital Advantage's Medtronic position peaked at $369K in Q1 2021.
2,003 funds tracked by Wall St. Rank held Medtronic as of Q2 2021.

Based on Capital Advantage's 13F filing for Q2 2021, filed 16 Aug 2021.